Stock QGEN QIAGEN N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Qiagen N.V.

Equities

QGEN

NL0015001WM6

Market Closed - Nyse
Other stock markets
 16:00:02 2024-05-02 EDT 		5-day change 1st Jan Change
42.68 USD -0.30% Intraday chart for Qiagen N.V. +3.89% -4.68%
04-30 QIAGEN NV : Berenberg reaffirms its Buy rating ZD
04-30 QIAGEN : A decent start to 2024; guidance unchanged Alphavalue

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
AQ
Qiagen N : First Quarter 2024 SEC Filing
PU
Q1 2024 Results Conference Call Presentation: April 30, 2023
PU
Qiagen N : QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
PU
Q1 2024 Results Press Release: April 29, 2024, 22:05 CET
PU
Qiagen: Q1 Earnings Snapshot
AQ
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
AQ
Qiagen N : 2023 Annual Report 2023 IFRS Annual Report
PU
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
AQ
QIAGEN N.V. to release results for Q1 2024 and hold webcast
AQ
Qiagen N : launches new solution for screening of sexual assault forensic casework samples
PU
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
AQ
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
AQ
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
AQ
Qiagen N : Virtual Exane Conference Investor Introduction
PU
Qiagen N : TD Cowen Healthcare Conference March 5-6 Investor Introduction
PU
QIAGEN announces Form 20-F annual report filing for 2023 results
AQ
For the UK: QIAGEN Ltd statement about the Modern Slavery Act 2015 for 2024
PU
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
AQ
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certification
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QGEN Stock
  4. News Qiagen N.V.
  5. Press Releases